CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30391% above fair value
$6.27+0.00 (0.00%)
Close on Nov 12, 2026Market cap $313.79MP/E –Yield –
CapsoVision EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for CapsoVision
CapsoVision has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?